-
Apr 13, 2012, 01:15 AM
by
Michael Croft
Forbes | GNS Healthcare executives discuss "real world outcomes" in clinical trials and the concept of "always-on" trials that are constantly gathering data.
Full story
-
Apr 12, 2012, 04:00 AM
by
Michael Croft
Wall Street Journal | With a week to go before Illumina's annual meeting, Roche sent another letter to shareholders yesterday assuring them that Illumina is not Apple. Illumina has made good use of a journalist's quote comparing the two companies, but Roche hopes to squelch such comparisons.
Full story
-
Apr 11, 2012, 04:40 AM
by
Michael Croft
Bio-IT World | SGI released SGI NAS yesterday, a full-featured, flexible enterprise-class open storage solution. SGI NAS fully integrated with the SGI Modular InfiniteStorage product family, and can start small and yet scale to multiple petabytes of unified storage according to business demands.
Full story
-
Apr 11, 2012, 04:05 AM
by
Michael Croft
Peninsula Press | Genomic Health's CEO is as invested in her team and her company as she is in patients. The company is pairing sequencing with diagnostics.
Full story
-
Apr 11, 2012, 04:00 AM
by
Michael Croft
Wired | When Amazon and the National Institutes of Health announced that all of the data from the 1000 Genomes Project would go into the Amazon Cloud, freely accessible to the public, that was just the beginning.
Full story
-
Apr 10, 2012, 03:10 AM
by
Michael Croft
Bio-IT World | SINGAPORE—Researchers in Singapore have identified over 600 previously unknown genes mutated in stomach cancer. Their findings were published online in Nature Genetics on April 8.
Full story
-
Apr 10, 2012, 01:35 AM
by
Michael Croft
The Guardian | The Wellcome Trust has joined the "academic spring"--an open access campaign lobbying for all research papers to be shared, saying that it will soon adopt more stringent methods to ensure that all of the research it funds is freely available to the public within six months of first publication.
Full story
-
Apr 10, 2012, 01:05 AM
by
Michael Croft
Xconomy | LiquidGrids re-launched its business and overhauled its technology at the end of March to carry out data mining on social media sites for pharma companies. The goal is to identify trends and help customers take advantage of marketing opportunities in social media.
Full story
-
Apr 9, 2012, 00:15 AM
by
Michael Croft
The Hook | A new Nature commentary finds that 9 of 10 pre-clinical cancer research studies cannot be replicated. Amgen researchers tried to confirm the findings of published academic research, and could only do so in 6 of the 53 papers they considered.
Full story
-
Apr 9, 2012, 00:05 AM
by
Michael Croft
Barron's | Shareholder advisory firm Institutional Shareholder Services has spoken up for Illumina in the Illumina-Roche standoff.
Full story
-
Apr 6, 2012, 03:10 AM
by
Michael Croft
News Brief | Takeda Pharmaceutical has joined the Structural Genomics Consortium (SGC), a public-private partnership that supports the discovery of new medicines through open access research. Takeda's contribution raises the SGC's funds to $50 million.
Full story
-
Apr 5, 2012, 03:05 AM
by
Michael Croft
Bio-IT World | Free trials & downloads featuring NGS plugins, aligner software, tox screening, ELNs, data visualization, digital signatures, and more.
Full story
-
Apr 5, 2012, 00:40 AM
by
Michael Croft
WSJ Health Blog | GE is increasing its investment in personalized medicine with the acquisition of SeqWright, a contract sequencing company in Houston.
Full story
-
Apr 5, 2012, 00:05 AM
by
Michael Croft
HHMI | Researchers from the Broad Institute have sequenced the genome of the three-spine stickleback, a small migratory fish, and have caught a glimpse of gene adaptations in action. Their findings are published today in Nature.
Full story
-
Apr 4, 2012, 07:00 AM
by
Michael Croft
Bio-IT World | It has taken more than a decade, but the ideas of Venkatesan Thangaraj to create a pharma pipeline for image management are maturing so quickly that he sees the potential of developing an industry standard that enables all trial sponsors and vendors to have a single customizable tool for handling clinical imaging data.
Full story
-
Apr 4, 2012, 03:00 AM
by
Michael Croft
Nature News | The American Association for Cancer Research meeting wraps up today, and has covered the gamut of topics from deep digital sequencing to fixing clinical trials to genomics-based cancer tests and predictions.
Full story
-
Apr 3, 2012, 08:00 AM
by
Michael Croft
Bio-IT World | Knome, the human genome interpretation company, made a series of announcements today, including its selection as a partner in the Illumina Genome Network (IGN) and a number of managerial appointments.
Full story
-
Apr 3, 2012, 03:00 AM
by
Michael Croft
Bio-IT World | The Skeptical Outsider | It's not a crisis. Yet. Bigger health care issues loom. Right now. There are still fortunes to be made. While it lasts. But one could hardly ask for a more interesting case study on the collision of medicine, economics, and democracy than the explosive growth of so-called orphan drugs. These are drugs designed to extract extraordinary amounts of other people's money serving the needs of tiny, desperate patient populations.
Full story
-
Apr 3, 2012, 02:40 AM
by
Michael Croft
New York Times | A study published yesterday online in Science Translational Medicine found that knowing a person's DNA doesn't seem to help predict a person's medical future.
Full story
-
Apr 3, 2012, 02:35 AM
by
Michael Croft
Mass High Tech | RainDance Technologies has announced worldwide release of its cancer mutation screening panel, which screens 13,000 cancer hotspots across 54 genes.
Full story